# The Plasma Diafiltration Therapy of Hepatic Failure

> **NCT03560414** · NA · UNKNOWN · sponsor: **Fuzhou General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Hepatic Failure
- Plasma Exchange

## Interventions

- **PROCEDURE:** simple plasma exchange
- **PROCEDURE:** conventional PDF treatment group
- **PROCEDURE:** less plasma PDF treatment group

## Key facts

- **NCT ID:** NCT03560414
- **Lead sponsor:** Fuzhou General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06
- **Primary completion:** 2020-06
- **Final completion:** 2020-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03560414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03560414, "The Plasma Diafiltration Therapy of Hepatic Failure". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03560414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*